Vor Biopharma Inc. VOR
Regular-session close
After hours · Nov 20, 4:39 PM ET
- YTD
- +46.71%
- 1 year
- +179.74%
Held by funds
78 US ETFs and mutual funds hold VOR · largest positions
- FIDGX 0.32% of fund $28.55M
- FBIOX 0.45% of fund $26.70M
- VTI 0.00% of fund $24.06M
- XBI 0.21% of fund $20.31M
- IWM 0.02% of fund $18.11M
- FDSCX 0.23% of fund $17.04M
- FSSNX 0.03% of fund $10.21M
- VXF 0.01% of fund $8.62M
- FSCRX 0.36% of fund $8.07M
- FBTTX 0.28% of fund $6.56M
- FESM 0.07% of fund $4.80M
- IWO 0.03% of fund $4.54M
- VTWO 0.02% of fund $4.45M
- SCHA 0.02% of fund $3.78M
- FSMAX 0.01% of fund $3.44M
- FSMO 0.16% of fund $2.31M
- IWC 0.18% of fund $2.14M
- FSLCX 0.16% of fund $2.10M
- IWN 0.01% of fund $2.01M
- FSKAX 0.00% of fund $1.43M
Ownership
- Institutions 90.5%
- Insiders 8.92%
- Public and other holders 0.55%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 11.00% | 6,759,007 | 129.71M | Sep 29, 2026 |
| TCG Crossover Management, LLC | 9.23% | 5,673,078 | 108.87M | Sep 29, 2026 |
| RA Capital Management, L.P. | 7.33% | 4,503,882 | 86.43M | Sep 29, 2026 |
| FCPM III Services B.V. | 5.54% | 3,405,279 | 65.35M | Sep 29, 2026 |
| Blackrock Inc. | 5.38% | 3,306,494 | 63.45M | Sep 29, 2026 |
| Venrock Adviser, LLC | 4.95% | 3,041,719 | 58.37M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.52% | 1,550,885 | 29.76M | Jun 29, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 2.28% | 1,399,605 | 26.86M | Sep 29, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 2.07% | 1,270,144 | 24.37M | Aug 30, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.78% | 1,091,626 | 20.95M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.62% | 996,334 | 19.12M | Sep 29, 2026 |
| Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund | 1.23% | 758,112 | 14.55M | Aug 30, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs VOR, and what each was last paid
Jean-Paul Kress, Chairman, President & CEOAverage age 56
| Name | Title | Pay | Age |
|---|---|---|---|
| Jean-Paul Kress | Chairman, President & CEO | $1.01M | 61 |
| Robert Ang MBBS | Strategic Advisor | $2.00M | 52 |
| Jeremy Sokolove | Chief Medical Officer | $695K | 52 |
| Sandesh Mahatme | Chief Business Officer & Chief Financial Officer | $604K | 61 |
| Navid Z. Khan | Chief Medical Affairs Officer | — | — |
| Siddhartha Mukherjee DPHIL | Scientific Founder & Chairman of Scientific Advisory Board | — | 55 |
| Adi Osovsky | General Counsel | — | — |
| Carol Lincoln | Head of Human Resources | — | — |
| Dallan Murray | Chief Commercial Officer | — | 56 |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANG ROBERT M.D. | Chief Executive Officer | Stock Award(Grant) | Feb 2, 2025 | 921,739 |
| ATTAR EYAL C | Officer | Sale | Feb 12, 2025 | 126,625 |
| CHAKRABORTY TIRTHA | Officer | Stock Award(Grant) | Feb 2, 2025 | 221,272 |
| CHOI HAN WOOK | Chief Financial Officer | Stock Award(Grant) | Feb 2, 2025 | 52,500 |
| MAHATME SANDESH | Chief Financial Officer | Stock Award(Grant) | Jul 8, 2025 | 13,882,800 |
| RA CAPITAL HEALTHCARE FUND,L.P. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Aug 23, 2026 | 0 |
